• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804250-08
Device Problems Entrapment of Device (1212); Failure to Advance (2524); Device Dislodged or Dislocated (2923); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2023
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a heavily calcified, heavily tortuous left main into ostial left circumflex (lcx) artery.Two unspecified stents were implanted and a third 2.5x08mm xience skypoint stent delivery system (sds) was attempted to advance.However, it was stent had a tough time pushing it around the left main bend into the lcx.The struts at the proximal end of the stent fished scaled off the edge of the balloon due to the severe angle and the sds could not be pulled back.Therefore, the guideliner was brought up to the edge of the stent and was pulled out as a whole, jammed on the edge of the guideliner.Another xience skypoint stent was used to successfully complete the procedure.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
The device was returned for analysis.The reported material deformation was confirmed.The reported failure to advance and entrapment with the vessel could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: medical device problem code 2923 removed, 2976 added.
 
Event Description
Subsequently, after the initial report was filed, return device analysis and follow up with the account confirmed that the stent remained on the delivery system the stent did not dislodge; however, the stent strut was flared.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18103737
MDR Text Key327753758
Report Number2024168-2023-12479
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233050
UDI-Public08717648233050
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/07/2024
Device Catalogue Number1804250-08
Device Lot Number2030241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/01/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2023
Initial Date FDA Received11/09/2023
Supplement Dates Manufacturer Received01/16/2024
Supplement Dates FDA Received02/08/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexMale
-
-